Galantamine worth it for AD in many countries

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2004

Schlagwörter:	Placebo Clinical Trial Health Care Health Care System Healthcare System

Anmerkung:	© Adis International Ltd 2004

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1455(2004), 1 vom: Sept., Seite 4-4
Übergeordnetes Werk:	volume:1455 ; year:2004 ; number:1 ; month:09 ; pages:4-4

Links:	Volltext

DOI / URN:	10.2165/00128413-200414550-00007

Katalog-ID:	SPR035198184

Internformat


LEADER	01000caa a22002652 4500
001	SPR035198184
003	DE-627
005	20230519100708.0
007	cr uuu---uuuuu
008	201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200414550-00007 \|2 doi
035			\|a (DE-627)SPR035198184
035			\|a (SPR)00128413-200414550-00007-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Galantamine worth it for AD in many countries
264		1	\|c 2004
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2004
650		4	\|a Placebo \|7 (dpeaa)DE-He213
650		4	\|a Clinical Trial \|7 (dpeaa)DE-He213
650		4	\|a Health Care \|7 (dpeaa)DE-He213
650		4	\|a Health Care System \|7 (dpeaa)DE-He213
650		4	\|a Healthcare System \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1455(2004), 1 vom: Sept., Seite 4-4 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1455 \|g year:2004 \|g number:1 \|g month:09 \|g pages:4-4
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200414550-00007 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1455 \|j 2004 \|e 1 \|c 09 \|h 4-4

Indexfelder

matchkey_str	article:22306056:2004----::aatmnwrhtoaim
hierarchy_sort_str	2004
publishDate	2004
allfields	10.2165/00128413-200414550-00007 doi (DE-627)SPR035198184 (SPR)00128413-200414550-00007-e DE-627 ger DE-627 rakwb eng Galantamine worth it for AD in many countries 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Placebo (dpeaa)DE-He213 Clinical Trial (dpeaa)DE-He213 Health Care (dpeaa)DE-He213 Health Care System (dpeaa)DE-He213 Healthcare System (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1455(2004), 1 vom: Sept., Seite 4-4 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1455 year:2004 number:1 month:09 pages:4-4 https://dx.doi.org/10.2165/00128413-200414550-00007 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1455 2004 1 09 4-4
spelling	10.2165/00128413-200414550-00007 doi (DE-627)SPR035198184 (SPR)00128413-200414550-00007-e DE-627 ger DE-627 rakwb eng Galantamine worth it for AD in many countries 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Placebo (dpeaa)DE-He213 Clinical Trial (dpeaa)DE-He213 Health Care (dpeaa)DE-He213 Health Care System (dpeaa)DE-He213 Healthcare System (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1455(2004), 1 vom: Sept., Seite 4-4 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1455 year:2004 number:1 month:09 pages:4-4 https://dx.doi.org/10.2165/00128413-200414550-00007 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1455 2004 1 09 4-4
allfields_unstemmed	10.2165/00128413-200414550-00007 doi (DE-627)SPR035198184 (SPR)00128413-200414550-00007-e DE-627 ger DE-627 rakwb eng Galantamine worth it for AD in many countries 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Placebo (dpeaa)DE-He213 Clinical Trial (dpeaa)DE-He213 Health Care (dpeaa)DE-He213 Health Care System (dpeaa)DE-He213 Healthcare System (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1455(2004), 1 vom: Sept., Seite 4-4 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1455 year:2004 number:1 month:09 pages:4-4 https://dx.doi.org/10.2165/00128413-200414550-00007 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1455 2004 1 09 4-4
allfieldsGer	10.2165/00128413-200414550-00007 doi (DE-627)SPR035198184 (SPR)00128413-200414550-00007-e DE-627 ger DE-627 rakwb eng Galantamine worth it for AD in many countries 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Placebo (dpeaa)DE-He213 Clinical Trial (dpeaa)DE-He213 Health Care (dpeaa)DE-He213 Health Care System (dpeaa)DE-He213 Healthcare System (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1455(2004), 1 vom: Sept., Seite 4-4 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1455 year:2004 number:1 month:09 pages:4-4 https://dx.doi.org/10.2165/00128413-200414550-00007 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1455 2004 1 09 4-4
allfieldsSound	10.2165/00128413-200414550-00007 doi (DE-627)SPR035198184 (SPR)00128413-200414550-00007-e DE-627 ger DE-627 rakwb eng Galantamine worth it for AD in many countries 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Placebo (dpeaa)DE-He213 Clinical Trial (dpeaa)DE-He213 Health Care (dpeaa)DE-He213 Health Care System (dpeaa)DE-He213 Healthcare System (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1455(2004), 1 vom: Sept., Seite 4-4 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1455 year:2004 number:1 month:09 pages:4-4 https://dx.doi.org/10.2165/00128413-200414550-00007 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1455 2004 1 09 4-4
language	English
source	Enthalten in Inpharma weekly 1455(2004), 1 vom: Sept., Seite 4-4 volume:1455 year:2004 number:1 month:09 pages:4-4
sourceStr	Enthalten in Inpharma weekly 1455(2004), 1 vom: Sept., Seite 4-4 volume:1455 year:2004 number:1 month:09 pages:4-4
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Placebo Clinical Trial Health Care Health Care System Healthcare System
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2004-09-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035198184
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035198184</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519100708.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414550-00007</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035198184</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414550-00007-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Galantamine worth it for AD in many countries</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Placebo</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trial</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Care</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Care System</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Healthcare System</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1455(2004), 1 vom: Sept., Seite 4-4</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1455</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:4-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414550-00007</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1455</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">09</subfield><subfield code="h">4-4</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Galantamine worth it for AD in many countries Placebo (dpeaa)DE-He213 Clinical Trial (dpeaa)DE-He213 Health Care (dpeaa)DE-He213 Health Care System (dpeaa)DE-He213 Healthcare System (dpeaa)DE-He213
topic	misc Placebo misc Clinical Trial misc Health Care misc Health Care System misc Healthcare System
spellingShingle	misc Placebo misc Clinical Trial misc Health Care misc Health Care System misc Healthcare System Galantamine worth it for AD in many countries
topic_unstemmed	misc Placebo misc Clinical Trial misc Health Care misc Health Care System misc Healthcare System
topic_browse	misc Placebo misc Clinical Trial misc Health Care misc Health Care System misc Healthcare System
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Galantamine worth it for AD in many countries
ctrlnum	(DE-627)SPR035198184 (SPR)00128413-200414550-00007-e
title_full	Galantamine worth it for AD in many countries
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2004
contenttype_str_mv	txt
container_start_page	4
container_volume	1455
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200414550-00007
title_sort	galantamine worth it for ad in many countries
title_auth	Galantamine worth it for AD in many countries
abstract	© Adis International Ltd 2004
abstractGer	© Adis International Ltd 2004
abstract_unstemmed	© Adis International Ltd 2004
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Galantamine worth it for AD in many countries
url	https://dx.doi.org/10.2165/00128413-200414550-00007
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200414550-00007
up_date	2024-07-03T13:51:14.631Z
_version_	1803566107470069760
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035198184</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519100708.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414550-00007</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035198184</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414550-00007-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Galantamine worth it for AD in many countries</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Placebo</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trial</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Care</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Care System</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Healthcare System</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1455(2004), 1 vom: Sept., Seite 4-4</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1455</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:4-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414550-00007</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1455</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">09</subfield><subfield code="h">4-4</subfield></datafield></record></collection>
score	7.400941

Nicht das Richtige dabei?

Schreiben Sie uns!

Galantamine worth it for AD in many countries

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?